DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Mingeun | ko |
dc.contributor.author | Park, Min Hee | ko |
dc.contributor.author | Nam, Geewoo | ko |
dc.contributor.author | Lee, Misun | ko |
dc.contributor.author | Kang, Juhye | ko |
dc.contributor.author | Song, Im-Sook | ko |
dc.contributor.author | Choi, Min-Koo | ko |
dc.contributor.author | Jin, Hee Kyung | ko |
dc.contributor.author | Bae, Jae-Sung | ko |
dc.contributor.author | Lim, Mi Hee | ko |
dc.date.accessioned | 2021-02-09T02:10:06Z | - |
dc.date.available | 2021-02-09T02:10:06Z | - |
dc.date.created | 2021-01-13 | - |
dc.date.issued | 2021-01 | - |
dc.identifier.citation | MOLECULAR PHARMACEUTICS, v.18, no.1, pp.101 - 112 | - |
dc.identifier.issn | 1543-8384 | - |
dc.identifier.uri | http://hdl.handle.net/10203/280669 | - |
dc.description.abstract | We report a prodrug, Glu-DAPPD, to overcome the shortcomings of an anti-neuroinflammatory molecule, N,N'-diacetyl-p-phenylenediamine (DAPPD), in biological applicability for potential therapeutic applications. We suspect that Glu-DAPPD can release DAPPD through endogenous enzymatic bioconversion. Consequently, Glu-DAPPD exhibits in vivo efficacies in alleviating neuroinflammation, reducing amyloid-beta aggregate accumulation, and improving cognitive function in Alzheimer's disease transgenic mice. Our studies demonstrate that the prodrug approach is suitable and effective toward developing drug candidates against neurodegeneration. | - |
dc.language | English | - |
dc.publisher | AMER CHEMICAL SOC | - |
dc.title | A Glycosylated Prodrug to Attenuate Neuroinflammation and Improve Cognitive Deficits in Alzheimer's Disease Transgenic Mice | - |
dc.type | Article | - |
dc.identifier.wosid | 000606803900008 | - |
dc.identifier.scopusid | 2-s2.0-85097750576 | - |
dc.type.rims | ART | - |
dc.citation.volume | 18 | - |
dc.citation.issue | 1 | - |
dc.citation.beginningpage | 101 | - |
dc.citation.endingpage | 112 | - |
dc.citation.publicationname | MOLECULAR PHARMACEUTICS | - |
dc.identifier.doi | 10.1021/acs.molpharmaceut.0c00677 | - |
dc.contributor.localauthor | Lim, Mi Hee | - |
dc.contributor.nonIdAuthor | Park, Min Hee | - |
dc.contributor.nonIdAuthor | Nam, Geewoo | - |
dc.contributor.nonIdAuthor | Lee, Misun | - |
dc.contributor.nonIdAuthor | Kang, Juhye | - |
dc.contributor.nonIdAuthor | Song, Im-Sook | - |
dc.contributor.nonIdAuthor | Choi, Min-Koo | - |
dc.contributor.nonIdAuthor | Jin, Hee Kyung | - |
dc.contributor.nonIdAuthor | Bae, Jae-Sung | - |
dc.description.isOpenAccess | N | - |
dc.type.journalArticle | Article | - |
dc.subject.keywordAuthor | Alzheimer&apos | - |
dc.subject.keywordAuthor | s disease | - |
dc.subject.keywordAuthor | prodrug | - |
dc.subject.keywordAuthor | anti-neuroinflammation | - |
dc.subject.keywordAuthor | microglial function | - |
dc.subject.keywordAuthor | amyloid-beta | - |
dc.subject.keywordPlus | ARYLAMINE N-ACETYLTRANSFERASES | - |
dc.subject.keywordPlus | MESENCHYMAL STEM-CELLS | - |
dc.subject.keywordPlus | MICROGLIAL DYSFUNCTION | - |
dc.subject.keywordPlus | BETA-GLUCOSIDASES | - |
dc.subject.keywordPlus | SPECIFICITY | - |
dc.subject.keywordPlus | TARGET | - |
dc.subject.keywordPlus | METABOLISM | - |
dc.subject.keywordPlus | CLEARANCE | - |
dc.subject.keywordPlus | MECHANISM | - |
dc.subject.keywordPlus | PROTEIN | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.